Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on March 11, 2008
JNCI Journal of the National Cancer Institute 2008 100(6):380-381; doi:10.1093/jnci/djn072
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/6/380    most recent
djn072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Brower, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brower, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

Judah Folkman Leaves Expanding Legacy

Vicki Brower

The first 10% of the full text of this article appears below.

Known as the father of angiogenesis research, Judah Folkman, M.D., died suddenly on January 14, 2008, while traveling to a scientific meeting.


Figure Removed (Available Only in the Full Text)
View larger version (93K):



  		Judah Folkman, M.D., 1933–2008.

 
Folkman was a professor of cell biology and pediatric surgery at Harvard University and chair of vascular biology at Boston's Children Hospital. He pioneered the field of angiogenesis research, taking it from hypothesis to clinic in the space of three decades. Though 74, he was nowhere near slowing down. His work on the role of blood vessel growth in cancer was advancing rapidly, along with the field that he inspired.

Colleagues and students called Folkman "an electrifying lecturer," "extremely generous," "a mensch," and the reason they went into the field. Friends and associates remember his influence on cancer research and treatment, which continues to further his vision of making cancer a chronic, treatable disease.

"Folkman opened up a . . . [Full Text of this Article]

He Asked Why

Working Out the Details

Reducing Resistance, Toxicity

Folkman's Most Recent Studies Focused on Platelets


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?